These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9723263)

  • 1. Cyclosporine: has it made a difference between using HLA or not? A comparative study between patients with and without HLA matching.
    Juarez F; Barrios Y; Cano L; Chavez E; Camacho R; Gomez A; Maciel M; Borjon S; Limones M; Peniche L
    Transplant Proc; 1998 Aug; 30(5):1744-5. PubMed ID: 9723263
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
    Gracida C; Melchor JL
    Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression protocols for HLA identical renal transplant recipients.
    Keitel E; Santos AF; Alves MA; Neto JP; Schaefer PG; Bittar AE; Goldani JC; Pozza R; Bruno RM; See D; Garcia CD; Garcia VD
    Transplant Proc; 2003 May; 35(3):1074-5. PubMed ID: 12947863
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor.
    Papadimitriou M; Vakianis P; Malliara M; Economidou D; Alexopoulos E; Belechri AM; Koukoudis P; Papadopoulou D; Syrganis C; Polymenidis Z
    Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival.
    Peddi VR; Weiskittel P; Alexander JW; Woodle ES; First MR
    Transplant Proc; 2001; 33(7-8):3411-3. PubMed ID: 11750460
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 11. Strategy for improving retransplantation in the CyA era.
    Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
    Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
    [No Abstract]   [Full Text] [Related]  

  • 12. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results of kidney grafts surviving beyond the first year: comparison of cyclosporine-based regimens with the azathioprine and steroid regimen.
    Rizzolo M; Puggia R; Maresca MC; Calconi G; Vianello A
    Transplant Proc; 1998 Aug; 30(5):1751-2. PubMed ID: 9723266
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1999 Nov; 31(7A):31S-33S. PubMed ID: 10576040
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoral versus Sandimmune in kidney transplantation.
    Tisone G; Orlando G; Mercadante E; Vennarecci G; Pisani F; Buonomo O; Negrini S; Casciani CU
    Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.
    Abouna GM; al Arrayed AS; Farid E; Awad CK; Sharqawi SA; Tantawi M
    Transplant Proc; 1998 Dec; 30(8):4077-8. PubMed ID: 9865302
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 19. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G
    Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.